OLD National Bancorp IN Takes Position in LifeStance Health Group, Inc. $LFST

OLD National Bancorp IN bought a new position in LifeStance Health Group, Inc. (NASDAQ:LFST) in the third quarter, Holdings Channel.com reports. The firm bought 92,381 shares of the company’s stock, valued at approximately $508,000.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Squarepoint Ops LLC increased its holdings in shares of LifeStance Health Group by 259.1% in the second quarter. Squarepoint Ops LLC now owns 1,360,054 shares of the company’s stock valued at $7,031,000 after purchasing an additional 981,349 shares during the period. Cim Investment Management Inc. boosted its position in LifeStance Health Group by 100.8% in the second quarter. Cim Investment Management Inc. now owns 24,734 shares of the company’s stock valued at $128,000 after buying an additional 12,414 shares during the last quarter. State of Wyoming increased its holdings in LifeStance Health Group by 31.5% in the 2nd quarter. State of Wyoming now owns 86,629 shares of the company’s stock worth $448,000 after buying an additional 20,728 shares during the period. Tower Research Capital LLC TRC increased its holdings in LifeStance Health Group by 467.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 20,507 shares of the company’s stock worth $106,000 after buying an additional 16,893 shares during the period. Finally, Vident Advisory LLC raised its position in LifeStance Health Group by 12.7% during the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock worth $112,000 after buying an additional 2,447 shares during the last quarter. Institutional investors and hedge funds own 85.50% of the company’s stock.

Insider Transactions at LifeStance Health Group

In other LifeStance Health Group news, insider Ann Varanakis sold 50,000 shares of the company’s stock in a transaction on Wednesday, December 17th. The shares were sold at an average price of $6.90, for a total transaction of $345,000.00. Following the completion of the transaction, the insider directly owned 315,610 shares in the company, valued at approximately $2,177,709. This represents a 13.68% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, insider Lisa K. Miller sold 57,240 shares of the stock in a transaction on Friday, November 21st. The shares were sold at an average price of $6.43, for a total transaction of $368,053.20. Following the transaction, the insider directly owned 261,292 shares in the company, valued at approximately $1,680,107.56. The trade was a 17.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 327,326 shares of company stock valued at $2,259,317 in the last three months. 3.20% of the stock is currently owned by company insiders.

LifeStance Health Group Trading Up 0.5%

Shares of LifeStance Health Group stock opened at $7.10 on Friday. The firm has a 50-day simple moving average of $6.15 and a two-hundred day simple moving average of $5.41. The company has a debt-to-equity ratio of 0.18, a quick ratio of 1.58 and a current ratio of 1.58. LifeStance Health Group, Inc. has a fifty-two week low of $3.74 and a fifty-two week high of $8.30. The company has a market cap of $2.76 billion, a P/E ratio of -236.50 and a beta of 1.13.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings results on Wednesday, November 5th. The company reported $0.02 earnings per share for the quarter, beating the consensus estimate of ($0.01) by $0.03. The firm had revenue of $363.81 million during the quarter, compared to analyst estimates of $355.06 million. LifeStance Health Group had a negative return on equity of 0.62% and a negative net margin of 0.67%.LifeStance Health Group’s revenue for the quarter was up 16.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned ($0.02) EPS. As a group, equities analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research firms have recently commented on LFST. UBS Group upped their price objective on shares of LifeStance Health Group from $9.00 to $10.00 and gave the company a “buy” rating in a report on Friday, November 7th. Wall Street Zen lowered shares of LifeStance Health Group from a “buy” rating to a “hold” rating in a report on Saturday, October 11th. Zacks Research downgraded LifeStance Health Group from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, November 5th. Barclays started coverage on LifeStance Health Group in a report on Tuesday, December 9th. They issued an “overweight” rating and a $8.00 price objective for the company. Finally, BMO Capital Markets assumed coverage on LifeStance Health Group in a report on Thursday, November 13th. They set an “outperform” rating and a $8.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, five have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $8.83.

LifeStance Health Group Company Profile

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.